Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation

Area of Science:

• Immunology
• Hepatology
• Transplantation

Background:

• Hepatitis C virus (HCV) recurrence post-orthotopic liver transplantation (OLT) and acute cellular rejection mechanisms are not fully elucidated.
• Understanding the immune response in HCV recurrence is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the frequency and function of CD4(+)/CD25(+) T-cells in patients with HCV recurrence after OLT.
• To compare these immune cells with those in patients experiencing chronic HCV infection.

Main Methods:

• Flow cytometry was used to enumerate CD4(+)/CD25(+) T-cells (including FoxP3 staining) in 20 patients with HCV recurrence post-OLT (Group A).
• Treg suppressor activity was measured by assessing inhibition of autologous CD4(+)/CD25(-) T-cell proliferation.
• Eight patients with chronic hepatitis C (Group B) and 10 healthy individuals (Group C) served as controls.

Main Results:

• No significant difference in CD4(+)/CD25(+) T-cell frequency or function was observed between patients with HCV recurrence (Group A) and those with chronic infection (Group B).
• Both Group A and Group B exhibited significantly higher CD4(+)/CD25(+) T-cell levels compared to healthy controls (Group C).

Conclusions:

• Patients with HCV recurrence post-OLT share a similar immunoregulatory network with those developing persistent HCV infection.
• CD4(+)/CD25(+) T-cell numbers may serve as a predictive marker for HCV recurrence following OLT.